Pharmaceutical Glass Packaging Market
Description
Size, Share & Trends Analysis Report By Material (Type I, Type II, Type III), By Product (Vials, Bottles, Ampoules), By Drug (Generic, Branded, Biologic), By Region, And Segment Forecasts, 2026 - 2033
Pharmaceutical Glass Packaging Market Summary
The global pharmaceutical glass packaging market size was estimated at USD 23.40 billion in 2025 and is projected to reach USD 51.56 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. Extensive utilization of generic injectable drugs coupled with high demand from the pharmaceutical industry is anticipated to drive market growth.
Limestone (CaCO3), soda ash (Na2CO3), cullet, and sand (SiO2) comprise the overall chemical composition of glass. For pharmaceutical packaging applications, the most common cations found in glassware are barium, zinc, ferrous, magnesium, calcium, potassium, sodium, boron, aluminum, and silicon. These materials influence the properties of glass such as chemical resistance, hardness, and durability.
The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to the drug delivery products. Multiple manufacturers working in pharmaceutical glass manufacturing industry are focused on packaging aimed at increasing shelf life of a product and are therefore investing in vials.
Pharmaceutical glass packaging developers have been enhancing their product capabilities to cater to the changing pharmaceutical industry, which can further contribute to the market growth in the U.S. For instance, in November 2023, Corning Incorporated introduced coated specially engineered Type I borosilicate vials known as Corning Velocity Vials. These vials exhibit effective hardness compared to conventional borosilicate vials, reducing the probability of cracking and breaking.
Glass poses as a hindrance to atmospheric gases such as carbon dioxide and oxygen from entering the primary pharmaceutical glass container, mitigating the risk of contamination of the drugs. Glass packaging lowers the susceptibility of drugs to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in near future.
The pharmaceutical glass packaging industry is poised for significant growth and innovation. Given its recyclable nature, the industry's increasing focus on sustainability and environmentally friendly packaging solutions positions glass as an attractive choice, which aligns well with pharmaceutical companies' heightened emphasis on sustainable practices. Integrating intelligent packaging technologies, such as RFID tags and tamper-evident features, enhances the appeal and functionality of pharmaceutical glass packaging. In response to tightening regulations on pharmaceutical packaging, manufacturers that offer inventive, compliant, and cost-effective glass packaging solutions are well-positioned to capture substantial market share.
Global Pharmaceutical Glass Packaging Market Report Segmentation
This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical glass packaging market report based on material, product, drug, material, and region:
Pharmaceutical Glass Packaging Market Summary
The global pharmaceutical glass packaging market size was estimated at USD 23.40 billion in 2025 and is projected to reach USD 51.56 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. Extensive utilization of generic injectable drugs coupled with high demand from the pharmaceutical industry is anticipated to drive market growth.
Limestone (CaCO3), soda ash (Na2CO3), cullet, and sand (SiO2) comprise the overall chemical composition of glass. For pharmaceutical packaging applications, the most common cations found in glassware are barium, zinc, ferrous, magnesium, calcium, potassium, sodium, boron, aluminum, and silicon. These materials influence the properties of glass such as chemical resistance, hardness, and durability.
The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to the drug delivery products. Multiple manufacturers working in pharmaceutical glass manufacturing industry are focused on packaging aimed at increasing shelf life of a product and are therefore investing in vials.
Pharmaceutical glass packaging developers have been enhancing their product capabilities to cater to the changing pharmaceutical industry, which can further contribute to the market growth in the U.S. For instance, in November 2023, Corning Incorporated introduced coated specially engineered Type I borosilicate vials known as Corning Velocity Vials. These vials exhibit effective hardness compared to conventional borosilicate vials, reducing the probability of cracking and breaking.
Glass poses as a hindrance to atmospheric gases such as carbon dioxide and oxygen from entering the primary pharmaceutical glass container, mitigating the risk of contamination of the drugs. Glass packaging lowers the susceptibility of drugs to degradation, such as hydrolysis and oxidation. Moreover, glass packaging helps in resisting escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in near future.
The pharmaceutical glass packaging industry is poised for significant growth and innovation. Given its recyclable nature, the industry's increasing focus on sustainability and environmentally friendly packaging solutions positions glass as an attractive choice, which aligns well with pharmaceutical companies' heightened emphasis on sustainable practices. Integrating intelligent packaging technologies, such as RFID tags and tamper-evident features, enhances the appeal and functionality of pharmaceutical glass packaging. In response to tightening regulations on pharmaceutical packaging, manufacturers that offer inventive, compliant, and cost-effective glass packaging solutions are well-positioned to capture substantial market share.
Global Pharmaceutical Glass Packaging Market Report Segmentation
This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical glass packaging market report based on material, product, drug, material, and region:
- Material Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- Type I
- Type II
- Type III
- Product Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- Vials
- Small vials
- Large vials
- Bottles
- Small bottles
- Large bottles
- Cartridges & Syringes
- Ampoules
- Drug Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- Generic
- Branded
- Biologic
- Regional Outlook (Volume, Million Units; Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Middle East & Africa
- Saudi Arabia
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Research Methodology
- 1.1.1. Market Segmentation
- 1.1.2. Market Definition
- 1.2. Research Scope & Assumptions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- 1.7. List of Abbreviations
- Chapter 2. Executive Summary
- 2.1. Market Snapshot, 2024 (USD Million)
- 2.2. Segmental Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Global Pharmaceutical Glass Packaging Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Marke Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Raw Material Trends
- 3.2.2. Manufacturing/Technology Trends
- 3.2.3. Sales Channel Analysis
- 3.3. Regulatory Framework
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Market Opportunity Analysis
- 3.4.4. Market Challenge Analysis
- 3.5. Business Environment Analysis
- 3.5.1. Porter’s Five Forces Analysis
- 3.5.2. PESTEL Analysis
- 3.6. Impact of Environmental, Social, and Governance (ESG) initiatives on the Pharmaceutical Glass Packaging Market
- 3.6.1. Market Differentiation
- 3.6.2. Regulatory Compliance
- 3.6.3. Industry Collaboration
- 3.6.4. Enhanced Brand Value
- 3.6.5. Addressing Consumer Demands
- Chapter 4. Pharmaceutical Glass Packaging Market: Price Trend Analysis
- 4.1. Pricing Trend Analysis, by Material, 2021 - 2033 (USD/Units)
- 4.2. Factors Affecting the Pricing Deviation
- Chapter 5. Pharmaceutical Glass Packaging Market: Material Estimates & Trend Analysis
- 5.1. Definition & Scope
- 5.2. Material Movement Analysis & Market Share, 2025 & 2033
- 5.3. Type I
- 5.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 5.4. Type II
- 5.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 5.5. Type III
- 5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- Chapter 6. Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis
- 6.1. Definition & Scope
- 6.2. Product Movement Analysis & Market Share, 2025 & 2033
- 6.3. Vials
- 6.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 6.4. Bottles
- 6.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 6.5. Cartridges & Syringes
- 6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 6.6. Ampoules
- 6.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- Chapter 7. Pharmaceutical Glass Packaging Market: Drug Estimates & Trend Analysis
- 7.1. Definition & Scope
- 7.2. Drug Movement Analysis & Market Share, 2025 & 2033
- 7.3. Generic
- 7.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 7.4. Branded
- 7.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 7.5. Biologic
- 7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- Chapter 8. Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis
- 8.1. Key Takeaways
- 8.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 8.3. North America
- 8.3.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.3.5. U.S.
- 8.3.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.3.6. Canada
- 8.3.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.3.7. Mexico
- 8.3.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.3.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.3.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.3.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4. Europe
- 8.4.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.5. Germany
- 8.4.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.6. UK
- 8.4.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.7. Italy
- 8.4.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.4.8. Spain
- 8.4.8.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.4.8.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.4.8.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.4.8.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5. Asia Pacific
- 8.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.5. China
- 8.5.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.6. India
- 8.5.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.7. Japan
- 8.5.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.8. South Korea
- 8.5.8.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.8.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.8.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.8.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.5.9. Australia
- 8.5.9.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.5.9.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.5.9.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.5.9.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.6. Central & South America
- 8.6.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.6.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.6.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.6.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.6.5. Brazil
- 8.6.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.6.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.6.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.6.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.7. Middle East & Africa
- 8.7.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.7.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.7.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.7.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- 8.7.5. Saudi Arabia
- 8.7.5.1. market estimates and forecasts, 2021 - 2033 (USD Million) (Million Units)
- 8.7.5.2. market estimates and forecasts, by material, 2021 - 2033 (Million Units) (USD Million)
- 8.7.5.3. market estimates and forecasts, by product, 2021 - 2033 (Million Units) (USD Million)
- 8.7.5.4. market estimates and forecasts, by drug, 2021 - 2033 (Million Units) (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Key Global Players & Recent Developments & Their Impact On the Industry
- 9.2. Key Company/Competition Categorization (Key innovators, Market leaders, emerging players)
- 9.3. List of key Raw Material Distributors and Channel Partners
- 9.4. List of Potential Customers, by End-use
- 9.5. Company Heat Map Analysis
- 9.6. Competitive Dashboard Analysis
- 9.7. Strategy Mapping
- 9.7.1. Capacity Expansion
- 9.7.2. Collaboration/ Partnerships/ Agreements
- 9.7.3. New Product launches
- 9.7.4. Mergers & Acquisitions
- 9.7.5. Innovation in Technology/ Material
- 9.7.6. Others
- Chapter 10. Company Listing / Profiles
- 10.1. Corning Incorporated
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.2. Nipro Corporation
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.3. SGD S.A.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.4. Stölzle-Oberglas GmbH
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.5. West Pharmaceutical Services, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.6. Schott AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.7. Gerresheimer AG
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.8. Bormioli Pharma S.r.l
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.9. Shandong Medicinal Glass Co., Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.10. Beatson Clark
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.11. Ardagh Group S.A.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.12. Arab Pharmaceutical Glass Co.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.13. Piramal Enterprises Ltd.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.14. Şişecam Group
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.15. Owens-Illinois, Inc
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.16. DWK Life Sciences
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
